Chargement en cours...
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer. The five-year survival rate of PDAC is very low (less than 8%), which is associated with the late diagnosis, high metastatic potential, and resistance to therapeutic agents. The identification of bet...
Enregistré dans:
| Publié dans: | Genes (Basel) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6827004/ https://ncbi.nlm.nih.gov/pubmed/31569425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes10100766 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|